10 To 15 Percent Of Women May Be Affected By Disordered Eating

Several maladaptive eating behaviors, beyond anorexia, can affect women. Indeed, some 10 to 15 percent of women have maladaptive eating behaviours and attitudes according to new study from the Université de Montréal and the Douglas Mental Health University Institute published in the International Journal of Eating Disorders…

Early Sexual Encounters Linked To Increased Risk Of Cervical Cancer Among Deprived Women, UK

One of the reasons why cervical cancer is more common among poorer women could be because they start having sex at a younger age than more affluent women, scientists have said…

Nearly 2 Million Women Attended Breast Screening In 2007/08, UK

The number of women attending breast screening has risen, with nearly two million accepting invitations from the NHS Breast Screening Programme in 2007/08, new figures show. The programme’s 2009 annual review shows that 1,994,651 women aged 50 to 70 attended screening in 2007/08, up by 93,418 on the previous year. Over 73 per cent of [...]

Human Genome Mapping Tops Reader Poll

The mapping of the human genome and translating that information into clinical application clearly was the number one medical advance of the decade, according to an e-mail survey of MedPage Today registered users.

Standards, Incentive Program for EHR Adoption Outlined

Just beating a year-end deadline, the Obama administration has released details of its program to encourage adoption of electronic health record systems by physicians and hospitals.

Readmission Rate Unaffected by Discharge Reporting (CME/CE)

A government effort to collect and report information on hospital discharge planning may do little to prevent unnecessary readmissions, according to an analysis of a large database.

No New Year’s Joy from FDA

The usual year-end rush of FDA approvals has been slowed by regulatory speed bumps as encountered by Pfizer’s updated pneumococcal conjugate vaccine Prevnar 13, and Basilea’s anti-MRSA agent ceftobiprole.

FDA, Health Plans Begin Study of Drug Effects in Pregnancy

A massive new database-driven study of effects of prescription drugs during pregnancy, called the Medication Exposure in Pregnancy Risk Evaluation Program (MEPREP), is getting under way under FDA sponsorship, the agency announced.

FDA evaluates Phase III randomized trial in acute myeloid leukemia

VION PHARMACEUTICALS, INC., announced today that the U.S. Food and Drug Administration (”FDA”) had responded to its Special Protocol Assessment (”SPA”) request to evaluate the Phase III randomized trial HOVON AML 92 sponsored by the Dutch-Belgian Cooperative Group for Hematology Oncology (”HOVON”) of its lead product Onrigin(TM).

Bionovo Announces Publication Describing First Novel Dual MTOR Inhibitor, BN107, For The Treatment Of Breast Cancer

Bionovo, Inc. (Nasdaq: BNVI) announced the publication of results from its study on the anti-tumor mechanism of BN107. The results of the study, published in the International Journal of Cancer, describe the potential molecular mechanisms mediating the selective pro-apoptotic (cell death) effect induced by BN107 on estrogen receptor negative (ER-) breast cancer cells…